German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk to support ...

German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk to support ...

Evotec and Novo Nordisk have partnered to develop off-the-shelf cell therapy products. The collaboration will focus on ...

Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial ...

While the companies did not reveal the financial details of the deal, Novo Nordisk will provide funding for two Evotec sites ...

Hamburg, Germany, 26 September 2024: Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that Evotec has entered a technology development ...

Evotec has entered a partnership with Novo Nordisk to develop next-generation off-the-shelf cell therapy technologies. Novo ...

In a report released today, Christian Ehmann from Warburg Research maintained a Buy rating on Evotec (0IRF – Research Report), with a ...

Evotec has joined forces with Novo Nordisk to advance the clinical and commercial manufacturing of stem cell-based therapies.

Shares of Evotec (ETR: EVTG)rose on Thursday after the company said it has entered a technology development partnership with ...

J.POD® Toulouse, France (EU) brings disruptive, scalable continuous biologics manufacturing technology to the region Just - ...

Discover Evotec SE's groundbreaking patent for ENaC-inhibiting compounds, offering innovative treatments for respiratory, skin, and ocular diseases. Explore their potential!